Explore 3 Stock Ideas & Industry Insights Download Free Report

Merger & Acquisition(M&A)

Uber (NYSE: UBER) to Buy Delivery Hero for $14.8 B, Creating Global Takeout Giant

Uber (NYSE: UBER) disclosed a €41.50 per‑share proposal for Germany‑based Delivery Hero, assigning an equity value of $14.8 B to the transaction. The price reflects an approximate 34% premium to the recent three‑month volume‑weighted average and a 9% uplift over the last closing price. …

Vinay Lochav | 17 July 2026

Uber (NYSE: UBER) to Buy Delivery Hero for $14.8 B, Creating Global Takeout Giant

Uber (NYSE: UBER) disclosed a €41.50 per‑share proposal for Germany‑based Delivery Hero, assigning an equity value of $14.8 B to the transaction. The price reflects an approximate 34% premium to the recent three‑month volume‑weighted average and a 9% uplift over the last closing price. …

Vinay Lochav | 17 July 2026

ConocoPhillips (NYSE: COP) Buys 42% Stake in BP’s Iraq Kirkuk Oil Venture

ConocoPhillips has agreed to purchase a 42% stake in BP’s Kirkuk oil venture in Iraq, a move that adds more than 3 billion barrels of recoverable resources to its portfolio. The deal, announced today, positions the Houston-based energy giant to expand its presence in …

Vinay Lochav | 17 July 2026

FGF Brands Buys Metro Bakery Site for C$90M in Canadian Food Sector Shift

Canada’s bakery sector is undergoing a structural shift as FGF Brands acquires Metro’s production facility in Baie-D’Urfé for C$90 million, a move that reshapes supply chains in Québec and Ontario. The deal hands FGF, Canada’s largest industrial baker, control of manufacturing and distribution for …

Vinay Lochav | 17 July 2026

Data443 to Issue $2M Note as Four Leaf Drops Prior Business Combination

Four Leaf Acquisition Corp. abandoned its planned merger with Chinese target XYDD after regulatory challenges under PRC law disrupted the transaction, redirecting its focus to a new business combination with cybersecurity firm Data443 Risk Mitigation. The transition, finalized on 15 July, includes a $2,000,000 …

Vinay Lochav | 17 July 2026

Merck (NYSE: MRK) Enters Takeover Fight for Personalis as Genomics Shares Surge

Merck (NYSE: MRK) is reported to be actively competing for the acquisition of Personalis, a small but strategically valuable genomics company. The rumor has propelled Personalis shares upward, reflecting investor optimism that a large‑scale deal could accelerate the firm’s integration into broader diagnostic platforms. …

Vinay Lochav | 17 July 2026

ConocoPhillips (NYSE: COP) Buys 42% of Iraqi Oil Unit From BP in $1.4 Billion Deal

The deal, part of a broader investment plan between the two companies, sent ConocoPhillips shares up 2.0% to $115.06 in recent trading, reflecting investor confidence in the strategic expansion. With a market capitalization of $137.5 billion, the company has outperformed this year, gaining 19.0% …

Vinay Lochav | 17 July 2026

Honeywell (NASDAQ: HON) Completes £1.3 Billion Catalyst Unit Acquisition

has closed its £1.3 billion purchase of Johnson Matthey’s Catalyst Technologies division, marking a strategic expansion into clean energy solutions. The acquisition, completed this month, adds advanced emissions control and sustainable fuel catalyst capabilities to Honeywell’s portfolio, positioning the industrial giant for growth in …

Vinay Lochav | 17 July 2026

AI Interconnect Market Expands as Palomino Labs (OTC: PALX) Secures Vega Links

Palomino Laboratories has signed a binding letter of intent to acquire Vega Links, a developer of high-speed interconnect infrastructure for artificial intelligence systems. The deal marks Palomino’s move to address a growing AI interconnect market. With exclusivity secured through September 2026, Palomino gains a …

Vinay Lochav | 17 July 2026

Jasper Therapeutics Merges With Kira, Secures $132M to Fund Pipeline Through 2028

Jasper Therapeutics has reshaped its clinical portfolio and balance sheet by completing an all‑stock acquisition of Kira Pharmaceuticals and simultaneously securing a private placement financing of approximately $132 million. The combined organization now possesses a suite of complement‑targeted and antibody‑based programs aimed at rare …

Vinay Lochav | 17 July 2026
Support

Hi! How can we help you today?

Loading…